Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gynecological Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06672497
What this trial is testing

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients

Who this might be right for
Breast CancerGynecologic CancersMitochondrial Function
University of South Carolina 30
Large-scale testing (Phase 3)UnknownNCT01871688
What this trial is testing

Pelvic Floor Rehabilitation for Gynecological Cancer Patients

Who this might be right for
Malignant Female Reproductive System Neoplasm
Seoul National University Bundang Hospital 100
Not applicableActive Not RecruitingNCT05591131
What this trial is testing

Genetic Testing in African Americans

Who this might be right for
Ovarian CancerEndometrial CancerPeritoneal Cancer
Augusta University 21
Not applicableUnknownNCT05561413
What this trial is testing

Gynaecology Exercise and Mindfulness Study

Who this might be right for
Gynecologic CancerUterus CancerOvary Cancer+3 more
University of Ulster 40
Early research (Phase 1)UnknownNCT05238818
What this trial is testing

Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors

Who this might be right for
Metastatic or Recurrent Gynecological Tumors
XinWu 36
Not applicableEnded earlyNCT03993210
What this trial is testing

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Who this might be right for
Gynecologic Tumor
Dana-Farber Cancer Institute 1
Not applicableStudy completedNCT00248911
What this trial is testing

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

Who this might be right for
Breast CancersGynecologic Cancer
Weill Medical College of Cornell University 94
Not applicableStudy completedNCT03681405
What this trial is testing

Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery

Who this might be right for
Ovarian NeoplasmUterine Neoplasm
Wake Forest University Health Sciences 31
Not applicableLooking for participantsNCT07044505
What this trial is testing

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

Who this might be right for
Gynecologic CancerGynecologic DiseaseGynecological Surgery+1 more
Stanford University 50
Not applicableStudy completedNCT02668913
What this trial is testing

LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer+1 more
Geoff Hall 72
Not applicableStudy completedNCT01990482
What this trial is testing

Influence of Coffee Intake on Postoperative Bowel Function After Comprehensive Staging Surgery for Gynecological Malignancies: A Randomized Controlled Trial.

Who this might be right for
Ilues
Erzincan Military Hospital 118
Testing effectiveness (Phase 2)UnknownNCT05051696
What this trial is testing

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

Who this might be right for
Genital Neoplasms, Female
Liu Zi 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738757
What this trial is testing

SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies

Who this might be right for
Recurrent or Metastatic MSI-H/dMMR Gynecological Malignancies
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT06906341
What this trial is testing

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms+1 more
Corcept Therapeutics 270
Not applicableUnknownNCT05313724
What this trial is testing

Mind-body Online Therapy in Gynecological Oncology

Who this might be right for
Gynecologic Cancer
Katja Haemmerli Keller 120
Not applicableStudy completedNCT02172638
What this trial is testing

Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management

Who this might be right for
Median Length of StayReadmission RateSurgery Related Complications Rate+1 more
Hospital Universitari Vall d'Hebron Research Institute 110
Not applicableStudy completedNCT03553784
What this trial is testing

Low-Intensity CBT for Gynaecological Cancer Survivors

Who this might be right for
Gynecological Cancer
University of Chester 32
Not applicableUnknownNCT03714581
What this trial is testing

Laser Therapy Following Radiotherapy for Gynecological Cancer

Who this might be right for
Pelvic RadiotherapyGynecological CancerDyspareunia+1 more
National and Kapodistrian University of Athens 112
Not applicableLooking for participantsNCT07259681
What this trial is testing

Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)

Who this might be right for
Pelvic ToxicityRadiation ToxicityChemotherapy Toxicity+7 more
Bernardino Clavo, MD, PhD 38
Not applicableLooking for participantsNCT05457595
What this trial is testing

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

Who this might be right for
Tumor RecurrenceMalignant Epithelial Neoplasm of VulvaMalignant Epithelial Tumor of Ovary+1 more
CNAO National Center of Oncological Hadrontherapy 55
Next Page